ibtayo Intravenous Infusion 350mg: Special drug-use Investigation for Cervical Cancer
Not Applicable
Recruiting
- Conditions
- Advanced or recurrent cervical cancer with disease progression after chemotherapy
- Registration Number
- JPRN-UMIN000052336
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence proportion of adverse drug reactions to safety specifications during the observation period
- Secondary Outcome Measures
Name Time Method